Summary
| Direction in ME/CFS | ↓ Reduced — lower than in the comparison group |
|---|---|
| Category | Functional |
| Also described as | Cardiopulmonary exercise test |
| Compared against | Day 1 vs Day 2 |
| Associated symptoms | PEM, exercise intolerance |
| Test type | Clinical or physiological test |
| Source | Lim et al. 2020 — doi:10.3390/jcm9124040 |
| Condition atlas | ME/CFS Biomarker Atlas |
Trials, interventions and tests
In clinical-trial registrations this marker maps to the outcome term Cardiopulmonary exercise testing (CPET) (25 registered trials use a matching outcome measure).
Clinical trials using 2-day CPET VO₂ peak (day 2) as an outcome
17 more trials reference this marker.
Interventions studied alongside this marker
Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.
- Exercise therapy — 8 trials, 6 PubMed co-citations
e.g. Predictive Equation for Peak Heart Rate and First Ventilatory Threshold Heart Rate in Patients With Coronary… - Losartan — 1 trial, 3 PubMed co-citations
e.g. Comparative effects of losartan and nifedipine therapy on exercise capacity, Doppler echocardiographic… - Pyridostigmine — 1 trial, 3 PubMed co-citations
e.g. Neurovascular Dysregulation and Acute Exercise Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue… - Cardiopulmonary Rehabilitation — 1 trial, 6 PubMed co-citations
e.g. Effects of Cardiopulmonary Rehabilitation on Cardiorespiratory Fitness and Clinical Symptom Burden in Long… - Coenzyme Q10 — 1 trial, 2 PubMed co-citations
e.g. Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled… - Endurance Training — 1 trial, 6 PubMed co-citations
e.g. VO(2) on-kinetics and aerobic exercise training in females with systemic lupus erythematosus. - Concurrent Training — 1 trial, 2 PubMed co-citations
e.g. Physiological Profiles of Male and Female CrossFit Athletes. - Inspiratory muscle training — 1 trial, 6 PubMed co-citations
e.g. Effects of physical rehabilitation interventions on pulmonary hypertension: an overview of systematic…
Related Functional markers in ME/CFS
Full list: ME/CFS Biomarker Atlas.
Frequently asked questions
Is 2-day CPET VO₂ peak (day 2) high or low in ME/CFS?
Reduced. Studies summarised in the OSMF atlas report lower 2-day CPET VO₂ peak (day 2) in ME/CFS than in the reference group of the cited comparison (Day 1 vs Day 2). Source: Lim et al. 2020.
What symptoms is 2-day CPET VO₂ peak (day 2) associated with in ME/CFS?
The cited literature associates this marker with PEM, exercise intolerance. These are population-level associations and do not mean the marker causes the symptoms.
Which test measures 2-day CPET VO₂ peak (day 2)?
It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.
Is one abnormal 2-day CPET VO₂ peak (day 2) result diagnostic of ME/CFS?
No. No single biomarker is diagnostic of ME/CFS. 2-day CPET VO₂ peak (day 2) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.
Cite this page
Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.